{"entity":{"type":"insider","cik":"0001770405","url":"/insider/0001770405","json_url":"/insider/0001770405.json","name":"JFL Capital Holdings LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":2,"first":"2019-04-09","last":"2019-07-02","span_basis":"filed_date"},"name_variants":[{"name":"JFL Capital Holdings LLC","source":"filing","n_filings":2,"first_seen":"2019-04-09","last_seen":"2019-07-02"}],"transactions":[{"id":8198910,"accession":"0000921895-19-001955","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000921895-19-001955","line_url":"/filing/0000921895-19-001955","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":null,"owner_name":"JFL Capital Management LP; JFL Capital Management, LLC; Lawler Joseph F.; JFL Capital Holdings LLC; JFL Partners Fund LP","owner_display_name":"JFL Capital Management LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17131.0,"shares_display":"17,131","price_per_share":5.848,"price_display":"5.85","price_state":"stated","total_value":100182.088,"total_display":"100,182.09","total_whole":"100,182","shares_owned_after":739676.0,"shares_owned_after_display":"739,676","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-02","filed_date":"2019-07-02","scope":"insider","n_lines":2},{"id":8198905,"accession":"0000921895-19-001955","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000921895-19-001955","line_url":"/filing/0000921895-19-001955","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":null,"owner_name":"JFL Capital Management LP; JFL Capital Management, LLC; Lawler Joseph F.; JFL Capital Holdings LLC; JFL Partners Fund LP","owner_display_name":"JFL Capital Management LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9593.0,"shares_display":"9,593","price_per_share":6.0029,"price_display":"6.00","price_state":"stated","total_value":57585.8197,"total_display":"57,585.82","total_whole":"57,586","shares_owned_after":729569.0,"shares_owned_after_display":"729,569","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-02","scope":"insider","n_lines":2},{"id":8198898,"accession":"0000921895-19-001955","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-19-001955","line_url":"/filing/0000921895-19-001955","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":null,"owner_name":"JFL Capital Management LP; JFL Capital Management, LLC; Lawler Joseph F.; JFL Capital Holdings LLC; JFL Partners Fund LP","owner_display_name":"JFL Capital Management LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23564.0,"shares_display":"23,564","price_per_share":5.945,"price_display":"5.94","price_state":"stated","total_value":140087.98,"total_display":"140,087.98","total_whole":"140,088","shares_owned_after":723910.0,"shares_owned_after_display":"723,910","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-28","filed_date":"2019-07-02","scope":"insider","n_lines":2},{"id":8508311,"accession":"0000921895-19-001055","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000921895-19-001055","line_url":"/filing/0000921895-19-001055","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":null,"owner_name":"JFL Capital Management LP; Lawler Joseph F.; JFL Partners Fund LP; JFL Capital Management, LLC; JFL Capital Holdings LLC","owner_display_name":"JFL Capital Management LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10990.0,"shares_display":"10,990","price_per_share":5.7264,"price_display":"5.73","price_state":"stated","total_value":62933.136,"total_display":"62,933.14","total_whole":"62,933","shares_owned_after":710008.0,"shares_owned_after_display":"710,008","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-08","filed_date":"2019-04-09","scope":"insider","n_lines":2},{"id":8508304,"accession":"0000921895-19-001055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-19-001055","line_url":"/filing/0000921895-19-001055#line-1","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":null,"owner_name":"JFL Capital Management LP; Lawler Joseph F.; JFL Partners Fund LP; JFL Capital Management, LLC; JFL Capital Holdings LLC","owner_display_name":"JFL Capital Management LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26288.0,"shares_display":"26,288","price_per_share":5.952,"price_display":"5.95","price_state":"stated","total_value":156466.176,"total_display":"156,466.18","total_whole":"156,466","shares_owned_after":703524.0,"shares_owned_after_display":"703,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-05","filed_date":"2019-04-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001274792","name":"MERRIMACK PHARMACEUTICALS INC","url":"/issuer/0001274792","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2019-04-09","last_seen":"2019-07-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001770405","retrieved_at":"2026-08-22T21:05:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}